Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Crispr Therapeutics Ag (CRSP)

Crispr Therapeutics Ag (CRSP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,622,662
  • Shares Outstanding, K 75,769
  • Annual Sales, $ 720 K
  • Annual Income, $ -348,870 K
  • 60-Month Beta 2.26
  • Price/Sales 13,036.69
  • Price/Cash Flow N/A
  • Price/Book 5.19
Trade CRSP with:

Options Overview

Details
  • Implied Volatility 62.47%
  • Historical Volatility 39.72%
  • IV Percentile 8%
  • IV Rank 18.22%
  • IV High 99.59% on 02/01/21
  • IV Low 54.20% on 05/27/21
  • Put/Call Vol Ratio 0.26
  • Today's Volume 1,418
  • Volume Avg (30-Day) 3,829
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 96,275
  • Open Int (30-Day) 98,040

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 4.19
  • Number of Estimates 8
  • High Estimate 10.43
  • Low Estimate -1.54
  • Prior Year -1.30
  • Growth Rate Est. (year over year) +422.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
104.69 +24.24%
on 05/17/21
130.39 -0.25%
on 06/14/21
+23.43 (+21.97%)
since 05/14/21
3-Month
95.11 +36.75%
on 05/11/21
137.59 -5.47%
on 04/26/21
-0.54 (-0.42%)
since 03/12/21
52-Week
59.19 +119.74%
on 06/15/20
220.20 -40.93%
on 01/15/21
+70.18 (+117.17%)
since 06/12/20

Most Recent Stories

More News
Thinking about trading options or stock in Crispr Therapeutics, AMC, Atomera, Prothena Corp, or Eli Lilly?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRSP, AMC, ATOM, PRTA, and LLY.

CRSP : 128.75 (+1.38%)
PRTA : 47.10 (+4.46%)
ATOM : 25.85 (+0.31%)
AMC : 57.00 (+15.38%)
LLY : 226.14 (+0.91%)
Vertex and CRISPR Therapeutics Present New Data in 22 Patients With Greater Than 3 Months Follow-Up Post-Treatment With Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001(TM) at European Hematology Association Annual Meeting

Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) and CRISPR Therapeutics (Nasdaq:CRSP) today announced new data on 22 patients, with follow-up of at least 3 months, and ranging from 4 months to 26 months,...

VRTX : 193.50 (+0.25%)
CRSP : 128.75 (+1.38%)
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $118.91, moving -0.24% from the previous trading session.

CRSP : 128.75 (+1.38%)
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $114.74, moving -0.92% from the previous trading session.

CRSP : 128.75 (+1.38%)
CRISPR Therapeutics AG (CRSP) Down 12.6% Since Last Earnings Report: Can It Rebound?

CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CRSP : 128.75 (+1.38%)
CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team...

CRSP : 128.75 (+1.38%)
Vertex and CRISPR Therapeutics to Present New Clinical Data on Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001(TM) For Severe Hemoglobinopathies at the Annual European Hematology Association Virtual Congress

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced two abstracts detailing updated data from the ongoing CTX001 clinical trials have been accepted...

VRTX : 193.50 (+0.25%)
CRSP : 128.75 (+1.38%)
CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer

-Collaboration brings together breakthrough gene editing technology and leading natural killer (NK) cell and T cell discovery, development, and manufacturing capabilities-

CRSP : 128.75 (+1.38%)
NKTX : 25.27 (+0.96%)
CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team...

CRSP : 128.75 (+1.38%)
Vertex (VRTX) Q1 Earnings Beat Estimates, Revenues Up Y/Y

Vertex (VRTX) beats both earnings and sales estimates in Q1 and keeps product sales outlook for 2021.

VRTX : 193.50 (+0.25%)
RGEN : 194.16 (+1.38%)
NBRV : 1.4300 (-0.69%)
CRSP : 128.75 (+1.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

See More

Key Turning Points

3rd Resistance Point 135.05
2nd Resistance Point 132.52
1st Resistance Point 129.76
Last Price 128.75
1st Support Level 124.47
2nd Support Level 121.94
3rd Support Level 119.18

See More

52-Week High 220.20
Fibonacci 61.8% 158.69
Fibonacci 50% 139.69
Last Price 128.75
Fibonacci 38.2% 120.70
52-Week Low 59.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar